APA (7th ed.) Citation

Baxter, G., Morgan, C., Jenkins-Jones, S., Currie, C., Schultewolter, D., Morgan, C. L., & Currie, C. J. (2015). Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary Care Observational Study. Value in Health, 18(7), A658. https://doi.org/10.1016/j.jval.2015.09.2385

Chicago Style (17th ed.) Citation

Baxter, G., CL Morgan, S. Jenkins-Jones, CJ Currie, D. Schultewolter, C L. Morgan, and C J. Currie. "Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary Care Observational Study." Value in Health 18, no. 7 (2015): A658. https://doi.org/10.1016/j.jval.2015.09.2385.

MLA (9th ed.) Citation

Baxter, G., et al. "Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary Care Observational Study." Value in Health, vol. 18, no. 7, 2015, p. A658, https://doi.org/10.1016/j.jval.2015.09.2385.